Cargando…

Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten

The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schellenberger, Mario T., Grova, Nathalie, Farinelle, Sophie, Willième, Stéphanie, Revets, Dominique, Muller, Claude P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364213/
https://www.ncbi.nlm.nih.gov/pubmed/22666501
http://dx.doi.org/10.1371/journal.pone.0038329
_version_ 1782234506900537344
author Schellenberger, Mario T.
Grova, Nathalie
Farinelle, Sophie
Willième, Stéphanie
Revets, Dominique
Muller, Claude P.
author_facet Schellenberger, Mario T.
Grova, Nathalie
Farinelle, Sophie
Willième, Stéphanie
Revets, Dominique
Muller, Claude P.
author_sort Schellenberger, Mario T.
collection PubMed
description The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vaccine to induce B[a]P specific antibodies (Grova et al., Vaccine. 2009;27:4142–51). Here, we investigated in mice the efficacy of B[a]P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a]P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a]P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a]P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a]P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a]P and B[a]P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a]P in the blood and modulate its faecal excretion (15–56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a]P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a pre-existing immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a]P are warranted.
format Online
Article
Text
id pubmed-3364213
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33642132012-06-04 Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten Schellenberger, Mario T. Grova, Nathalie Farinelle, Sophie Willième, Stéphanie Revets, Dominique Muller, Claude P. PLoS One Research Article The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vaccine to induce B[a]P specific antibodies (Grova et al., Vaccine. 2009;27:4142–51). Here, we investigated in mice the efficacy of B[a]P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a]P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a]P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a]P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a]P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a]P and B[a]P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a]P in the blood and modulate its faecal excretion (15–56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a]P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a pre-existing immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a]P are warranted. Public Library of Science 2012-05-30 /pmc/articles/PMC3364213/ /pubmed/22666501 http://dx.doi.org/10.1371/journal.pone.0038329 Text en Schellenberger et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Schellenberger, Mario T.
Grova, Nathalie
Farinelle, Sophie
Willième, Stéphanie
Revets, Dominique
Muller, Claude P.
Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title_full Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title_fullStr Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title_full_unstemmed Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title_short Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
title_sort immunogenicity of a promiscuous t cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364213/
https://www.ncbi.nlm.nih.gov/pubmed/22666501
http://dx.doi.org/10.1371/journal.pone.0038329
work_keys_str_mv AT schellenbergermariot immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten
AT grovanathalie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten
AT farinellesophie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten
AT williemestephanie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten
AT revetsdominique immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten
AT mullerclaudep immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten